Understanding Cancer Screening Tests Available in the UK
Cancer screening plays a vital role in detecting cancer at an early stage, when treatment is most likely to be effective. In the UK, the NHS offers several cancer screening programmes targeting specific populations at risk. These programmes, along with private testing options, provide a comprehensive approach to cancer prevention and early detection.
NHS Screening Programmes
The NHS offers three cancer screening programmes in the UK, targeting specific cancers and populations at risk.
Breast cancer screening is available for women aged 50 to 71, who are invited every three years for a mammogram to detect early signs of breast cancer.
Cervical screening (smear tests) is offered to women and people with a cervix aged 25 to 64, with intervals of three to five years depending on age, to detect high-risk HPV and abnormal cells that could lead to cervical cancer.
Bowel cancer screening is provided to individuals aged 60 to 74 (50 to 74 in Scotland) through a faecal immunochemical test (FIT) every two years to identify signs of bowel cancer. The NHS in England has expanded its bowel cancer screening programme to include individuals aged 50 and above (50-52 now included).
Previously, the programme targeted those aged 54 to 74, but now approximately 850,000 people aged 50 and 52 will receive at-home Faecal Immunochemical Test (FIT) kits every two years.
In addition, men aged 65 are invited for a one-time abdominal aortic aneurysm (AAA) screening, which can detect potential cancer-related complications. These screening programmes are designed to detect cancer early or identify precancerous changes, improving treatment outcomes and saving lives.
Benefits of Cancer Screening
Early Detection: Screening can identify cancer before symptoms appear, significantly improving the chances of successful treatment.
Reduced Mortality Rates: Early-stage cancers are often less aggressive and more treatable, reducing the likelihood of fatal outcomes.
Increased Awareness: Regular screening encourages individuals to monitor their health and report symptoms promptly.
Cost-Effectiveness: Early intervention can reduce the long-term financial burden on healthcare systems and individuals by avoiding advanced treatments.
Key Takeaways
Cancer screening is a powerful tool in the fight against cancer, providing the opportunity for early detection and better health outcomes. By participating in NHS screening programmes and considering private options where appropriate, individuals can take proactive steps to safeguard their health. Raising awareness about these tests and encouraging participation can save lives and improve the overall health of communities.
At Klarity, we are committed to empowering individuals and organisations with the tools and information needed to prioritise cancer prevention and early detection.
Here's a more detailed breakdown of cancer screening tests available in the UK, focusing on each cancer type, the specific tests used, and how they work.
1. Breast Cancer Screening
Primary Test: Mammogram
○
How it works: A mammogram is an X-ray of the breasts. During the procedure, the breast is compressed between two plates to spread out the tissue, allowing for a detailed X-ray image. This test detects calcifications, masses, or other abnormalities that could indicate breast cancer.
○
Who is eligible: Women aged 50 to 71 are invited every three years. Women under 50 may be offered screening if they have a strong family history of breast cancer or carry specific genetic mutations (e.g., BRCA1 or BRCA2).
Additional Tests:
○
Breast MRI: Recommended for women with a high genetic risk of breast cancer. This test uses magnetic fields to produce detailed images of breast tissue.
○
Breast Ultrasound: Often used to examine dense breast tissue or investigate abnormalities found during a mammogram.
2. Cervical Cancer Screening
Primary Test: Cervical Screening (Smear Test)
○
How it works: A sample of cells is collected from the cervix using a small brush. This sample is first tested for high-risk human papillomavirus (HPV) types that are known to cause cervical cancer. If high-risk HPV is detected, the sample is further examined for abnormal or precancerous cells (cytology).
○
Who is eligible: Women and individuals with a cervix aged 25 to 64.
○
Frequency: Every three years for ages 25-49 and every five years for ages 50-64.
Additional Tests (If Necessary):
○
Colposcopy: A follow-up procedure that provides a close-up view of the cervix to investigate abnormal smear results.
3. Bowel Cancer Screening
Primary Test: Faecal Immunochemical Test (FIT)
○
How it works: This at-home test kit involves collecting a small stool sample, which is then tested for tiny amounts of blood that are not visible to the naked eye. Blood in the stool can be a sign of bowel cancer or polyps.
○
Who is eligible: People aged 60 to 74 in England, Wales, and Northern Ireland, and 50 to 74 in Scotland.
○
Frequency: Every two years.
Additional Tests (If Necessary):
○
Colonoscopy: A procedure that uses a flexible tube with a camera to examine the inside of the colon and rectum for polyps or cancer.
○
CT Colonography: A CT scan that provides a detailed image of the colon and rectum. Often referred to as a virtual colonoscopy.
4. Lung Cancer Screening (Available in Targeted Programmes)
Primary Test: Low-Dose CT (LDCT) Scan
○
How it works: This imaging test uses low doses of radiation to create detailed images of the lungs. It is offered to individuals at high risk of lung cancer, such as current or former heavy smokers.
○
Who is eligible: Lung cancer screening is not yet a national programme but is offered in targeted trials and pilot programmes for high-risk individuals aged 55-74.
5. Prostate Cancer Screening
Primary Test: Prostate-Specific Antigen (PSA) Blood Test
○
How it works: This blood test measures PSA levels, a protein produced by the prostate gland. Elevated PSA levels can indicate prostate cancer, although they may also result from benign conditions like an enlarged prostate or infection.
○
Who is eligible: There is no national screening programme for prostate cancer, but men aged 50 and over can request a PSA test after discussing the benefits and risks with their GP.
Additional Tests (If Necessary):
○
MRI Scan: Provides detailed images of the prostate to identify suspicious areas.
○
Biopsy: Involves taking small samples of prostate tissue for laboratory analysis.
6. Skin Cancer Screening
Primary Test: Dermatological Examination
○
How it works: A dermatologist examines the skin for suspicious moles, lesions, or growths. Dermoscopy, a technique that uses a magnifying lens and light source, may be used to examine skin changes more closely.
○
Who is eligible: No national screening programme exists, but high-risk individuals (e.g., those with a history of sun exposure or skin cancer) are encouraged to undergo regular checks.
Additional Tests (If Necessary):
○
Skin Biopsy: A sample of skin is taken for microscopic examination.
7. Ovarian Cancer Screening
Primary Test: CA-125 Blood Test and Transvaginal Ultrasound (TVUS)
○
Tests: CA-125 Blood Test: Measures levels of the CA-125 protein, which can be elevated in ovarian cancer. Transvaginal Ultrasound (TVUS): Uses sound waves to create images of the ovaries and detect abnormalities.
○
Who is eligible: Screening is typically limited to women with a family history or genetic predisposition (e.g., BRCA mutations).
8. Abdominal Aortic Aneurysm (AAA) Screening
Primary Test: Abdominal Ultrasound
○
How it works: A painless ultrasound scan is used to measure the size of the aorta, the main blood vessel that runs through the abdomen. Although this is primarily aimed at preventing aortic rupture, it can also detect masses that may indicate certain cancers.
○
